Atosibano Accord

Atosiban is a synthetic peptide used for intravenous administration. It is primarily used to inhibit uterine contractions during preterm labor. This medication is manufactured by Accord Healthcare S.L.U. and is available in the EU market.

Atosiban is commonly used to delay preterm labor by inhibiting uterine contractions. It is often administered intravenously in clinical settings to manage this condition. The primary use of Atosiban is to provide temporary relief and allow for additional medical interventions if necessary.

Atosiban works by blocking oxytocin receptors in the uterus, which helps to reduce contractions. Common effects may include a decrease in uterine activity, which can provide temporary relief from preterm labor symptoms. It is important to monitor the patient's response to the medication closely.

Atosiban should be administered under medical supervision due to its intravenous route. It is essential to follow the prescribed guidelines and monitor the patient for any adverse reactions. Patients with a history of allergic reactions to similar medications should inform their healthcare provider before use.

Atosiban may interact with other medications that affect uterine contractions or blood pressure. It is important to inform your healthcare provider about all medications you are currently taking to avoid potential interactions. Always consult with a healthcare professional before combining Atosiban with other treatments.